Evidence map›Paper›PMID 42125700›Full record

ArticleFrontiers in oncology2026

Interpretability and performance of a 3D C-vit model for accurate grading of pediatric brain tumors.

Huixin Wu, Limeng Zhao, Yong Zhang, Can Zhang, Guohua Zhao, Wenjing Li, Yangyang Cheng, Xinxin Wang, Tan Ping, Xinyu Wang and 4 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Huixin WuSchool of Information Engineering, North China University of Water Resources and Electric Power, Zhengzhou, China.
Limeng ZhaoSchool of Information Engineering, North China University of Water Resources and Electric Power, Zhengzhou, China.
Yong ZhangDepartment of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Can ZhangSchool of Information Engineering, North China University of Water Resources and Electric Power, Zhengzhou, China.
Guohua ZhaoDepartment of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wenjing LiDepartment of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yangyang ChengSchool of Information Engineering, North China University of Water Resources and Electric Power, Zhengzhou, China.
Xinxin WangSchool of Information Engineering, North China University of Water Resources and Electric Power, Zhengzhou, China.
Tan PingSchool of Information Engineering, North China University of Water Resources and Electric Power, Zhengzhou, China.
Xinyu WangDepartment of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Fupeng WeiSchool of Information Engineering, North China University of Water Resources and Electric Power, Zhengzhou, China.
Qian ZhangSchool of Artificial Intelligence, Zhongyuan University of Technology, Zhengzhou, China.
Jie DongSchool of Information Engineering, North China University of Water Resources and Electric Power, Zhengzhou, China.
Weijian WangDepartment of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Accurate preoperative grading of pediatric brain tumors is crucial for formulating individualized treatment plans. Traditional methods rely on subjective experience, while existing deep learning models have limitations in capturing long-distance dependencies and local details. This study aims to develop and validate an innovative 3D hybrid deep learning model (3D C-Vit) for pediatric brain tumor grading and analyze its performance and interpretability. Methods: This retrospective study included 340 cases of pediatric brain tumors (143 low-grade cases and 197 high-grade cases). Tumor regions were independently annotated by two senior radiologists with consistency achieved. The data were divided into training, validation, and test sets in a ratio of 70:15:15. The model input included five MRI sequences: CE-T1WI, T1WI, T2WI, FLAIR, and ADC. The proposed 3D C-Vit model integrates the Channel Attention-Enhanced Feature Fusion (CAEFF) module, Multi-Scale Feature Extraction (MSFE) module, and Multi-Head Self-Attention (MHSA) mechanism. Model performance was evaluated using AUC, accuracy (ACC), precision, recall, and F1-score. Chi-square test and LASSO regression were used for feature selection and interpretability analysis. Results: The 3D C-Vit model performed optimally on the test set: AUC was 91.36%, ACC was 86.53%, and F1-score was 89.29. Ablation experiments confirmed that CAEFF, MSFE, and MHSA modules increased ACC by 6.92%, 11.67%, and 1.64%, respectively, and AUC by 6.79%, 11.14%, and 1.66%, respectively. Among the radiomics models, LASSO regression screened out 59 key features. The 3D C-Vit model was significantly superior to the clinical model (ACC 69.23%, AUC 79.09%) and the best radiomics models (SVM, ACC 77.55%, AUC 86.14%) in all assessment metrics. Conclusion: The 3D C-Vit model proposed in this study can effectively and automatically grade pediatric brain tumor, and its performance significantly surpasses traditional clinical methods and existing radiomics models. The model combines the local feature extraction capability of CNN with the global modeling advantage of Transformer and effectively improves the grading accuracy through the innovative CAEFF and MSFE modules. Its high accuracy and interpretability provide clinicians with a reliable preoperative tumor grading tool, which is helpful for quickly formulating precise individualized treatment plans.

Indexed as

feature interpretabilitygradingMRIpediatric brain tumortransformer

Identifiers

PMID42125700
PMCPMC13158093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.